retatrutide safety profile clinical trials The FDA has issued warning letters to multiple companies marketing compounded Today, we shared new data

A pivotal 2021 clinical study of more than 1,900 adults, known as the STEP 1 trial, laid the groundwork for the use of these drugs as a treatment for weight loss

No formal MHRA or NICE guidance exists on combining these agents

Why your sense of taste and smell changes when youre pregnant is understudied, says Dr

Certain GLP-1 formulations have demonstrated cardiovascular benefits in clinical trials, leading to specific FDA approvals: Victoza, Ozempic, and Trulicity are approved for reducing major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease, while Wegovy is approved for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight